Skip to main content
. 2015 Jan 13;19(3):608–619. doi: 10.1111/jcmm.12445

Fig 2.

Fig 2

miR-16 is down-regulated in hypertrophic cardiomyocytes. (A) Morphologies of PE-treated NRVCs as revealed by FITC-phalloidin staining. (B) ANP mRNA and miR-16 expressions were assessed by qRT-PCR assay (n + 3). (C) Morphologies of Ang-II-treated NMVCs as revealed by FITC-phalloidin staining. (D) ANP mRNA and miR-16 expressions were assessed by qRT-PCR assay (n + 3). Data are shown as mean ± SD; *P < 0.05, **P < 0.01 versus the Blank control.